Voyager Therapeutics, Inc.
VYGR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$28 | -$33 | -$31 | -$34 |
| Dep. & Amort. | $1 | -$1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $4 | $4 | $4 |
| Change in WC | -$8 | -$5 | -$12 | $17 |
| Other Non-Cash | $4 | $2 | $0 | -$1 |
| Operating Cash Flow | -$31 | -$33 | -$38 | -$15 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$7 | -$38 | -$77 | -$131 |
| Inv. Sales/Matur. | $42 | $41 | $119 | $104 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $35 | $2 | $41 | -$27 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $1 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1 |
| Financing Cash Flow | $0 | $1 | $0 | $1 |
| Forex Effect | -$3 | $0 | $0 | $0 |
| Net Chg. in Cash | $1 | -$31 | $3 | -$41 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44 | $78 | $74 | $115 |
| End Cash | $45 | $47 | $78 | $74 |
| Free Cash Flow | -$31 | -$34 | -$39 | -$15 |